MRI-based Glucose Assay Using Magnetic Nanoparticle Sensors.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Analytical Chemistry

Background:

• Direct glucose measurement is crucial for diabetes management.
• Existing methods often require complex sample preparation or lack specificity.
• Magnetic resonance relaxometry and imaging offer potential for non-invasive glucose sensing.

Purpose of the Study:

• To develop a novel magnetic glucose sensor for direct glucose measurement in biological samples.
• To utilize superparamagnetic iron oxide (SPIO) nanoparticles conjugated with mannopyranoside and concanavalin A (ConA).
• To assess the sensor's performance using NMR relaxometry and magnetic resonance imaging (MRI).

Main Methods:

• Conjugation of SPIO nanoparticles with a mannopyranoside derivative and ConA to create a glucose-responsive cluster.
• Measurement of changes in transverse relaxation time (T2) due to glucose-induced cluster dissociation.
• Validation of the sensor using a benchtop 1 tesla MRI scanner for sample analysis.

Main Results:

• The sensor demonstrated glucose-dependent changes in T2 at physiological glucose concentrations (3-8 mM).
• Significant T2 responses were detected within 6 minutes for 5 mM glucose.
• Multiple samples were analyzed within 8 minutes using sensor-based MRI.

Conclusions:

• The developed magnetic glucose sensor enables direct and rapid glucose detection.
• The sensor shows promise for high-throughput blood glucose assays.
• Integration with compact MRI scanners facilitates point-of-care testing applications.